Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Young-Kwon | - |
dc.contributor.author | Ahn, Dae-Ro | - |
dc.contributor.author | Oh, Myoungsuk | - |
dc.contributor.author | Lee, Taekyoung | - |
dc.contributor.author | Yang, Eun Gyeong | - |
dc.contributor.author | Son, Miwon | - |
dc.contributor.author | Park, Hyunsung | - |
dc.date.accessioned | 2024-01-20T23:03:09Z | - |
dc.date.available | 2024-01-20T23:03:09Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2008-07 | - |
dc.identifier.issn | 0026-895X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/133365 | - |
dc.description.abstract | We have confirmed that the NO donor (+/-)-S-nitroso-N-acetylpenicillamine (SNAP) stabilizes the transactive form of hypoxia-inducible factor-1 alpha (HIF-1 alpha), leading to the induction of HIF-1 alpha target genes such as vascular endothelial growth factor and carbonic anhydrase 9. Activation of HIF-1 alpha should require inhibition of the dual system that keeps it inactive. One is ubiquitination, which is triggered by hydroxylation of HIF-1 alpha proline and the subsequent binding of E3 ubiquitin ligase, the von Hippel Lindau (VHL) protein. The other is hydroxylation of HIF-1 alpha-asparagine, which reduces the affinity of HIF-1 alpha for its coactivator, cAMP responsive element binding protein/p300. We examined the effects of the NO donor SNAP on proline and asparagine hydroxylation of HIF-1 alpha peptides by measuring the activities of the corresponding enzymes, HIF-1 alpha-specific proline hydroxylase 2 (PHD2) and the HIF-1 alpha-specific asparagine hydroxylase, designated factor inhibiting HIF-1 alpha (FIH-1), respectively. We found that the SNAP did not prevent PHD2 from hydroxylating the proline of HIF-1 alpha. Instead, it blocked the interaction between VHL and the proline-hydroxylated HIF-1 alpha, but only when the reducing agents Fe(II) and vitamin C were limiting. The fact that the absence of cysteine 520 of HIF-1 alpha abolishes its responsiveness to SNAP suggests that this residue mediates the inhibition by SNAP of the interaction between VHL and HIF-1 alpha, presumably by S-nitrosylation of HIF-1 alpha. Unlike PHD2, asparagine hydroxylation by FIH-1 was directly inhibited by SNAP, but again only when reducing agents were limiting. Substitution of cysteine 800 of HIF-1 alpha with alanine failed to reverse the inhibitory effects of SNAP on asparagine hydroxylation, implying that FIH-1, not its substrate HIF-1 alpha, is inhibited by SNAP. | - |
dc.language | English | - |
dc.publisher | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS | - |
dc.subject | HYPOXIA-INDUCIBLE FACTOR | - |
dc.subject | HIF-1-ALPHA PROTEIN | - |
dc.subject | PROLYL HYDROXYLASES | - |
dc.subject | HIF-ALPHA | - |
dc.subject | TRANSCRIPTIONAL ACTIVITY | - |
dc.subject | CELL-METABOLISM | - |
dc.subject | S-NITROSYLATION | - |
dc.subject | NORMOXIC CELLS | - |
dc.subject | IN-VIVO | - |
dc.subject | OXYGEN | - |
dc.title | Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1 alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation | - |
dc.type | Article | - |
dc.identifier.doi | 10.1124/mol.108.045278 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | MOLECULAR PHARMACOLOGY, v.74, no.1, pp.236 - 245 | - |
dc.citation.title | MOLECULAR PHARMACOLOGY | - |
dc.citation.volume | 74 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 236 | - |
dc.citation.endPage | 245 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000256889600024 | - |
dc.identifier.scopusid | 2-s2.0-45749127802 | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | HYPOXIA-INDUCIBLE FACTOR | - |
dc.subject.keywordPlus | HIF-1-ALPHA PROTEIN | - |
dc.subject.keywordPlus | PROLYL HYDROXYLASES | - |
dc.subject.keywordPlus | HIF-ALPHA | - |
dc.subject.keywordPlus | TRANSCRIPTIONAL ACTIVITY | - |
dc.subject.keywordPlus | CELL-METABOLISM | - |
dc.subject.keywordPlus | S-NITROSYLATION | - |
dc.subject.keywordPlus | NORMOXIC CELLS | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | OXYGEN | - |
dc.subject.keywordAuthor | nitric oxide | - |
dc.subject.keywordAuthor | HIF | - |
dc.subject.keywordAuthor | VHL | - |
dc.subject.keywordAuthor | FIH | - |
dc.subject.keywordAuthor | hypoxia | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.